- Home
- DMN vs COSM Comparison
DMN vs COSM Comparison
Compare DMN & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMN
- COSM
- Stock Information
- Founded
- DMN 2020
- COSM 2009
- Country
- DMN Canada
- COSM United States
- Employees
- DMN N/A
- COSM N/A
- Industry
- DMN
- COSM Other Pharmaceuticals
- Sector
- DMN
- COSM Health Care
- Exchange
- DMN NYSE
- COSM Nasdaq
- Market Cap
- DMN 19.0M
- COSM 17.7M
- IPO Year
- DMN N/A
- COSM 2013
- Fundamental
- Price
- DMN $0.63
- COSM $0.66
- Analyst Decision
- DMN
- COSM
- Analyst Count
- DMN 0
- COSM 0
- Target Price
- DMN N/A
- COSM N/A
- AVG Volume (30 Days)
- DMN 681.0K
- COSM 161.6K
- Earning Date
- DMN 02-15-2025
- COSM 11-14-2024
- Dividend Yield
- DMN N/A
- COSM N/A
- EPS Growth
- DMN N/A
- COSM N/A
- EPS
- DMN N/A
- COSM N/A
- Revenue
- DMN N/A
- COSM $56,042,109.00
- Revenue This Year
- DMN N/A
- COSM $4.53
- Revenue Next Year
- DMN N/A
- COSM $25.00
- P/E Ratio
- DMN N/A
- COSM N/A
- Revenue Growth
- DMN N/A
- COSM 13.01
- 52 Week Low
- DMN $0.63
- COSM $0.47
- 52 Week High
- DMN $4.95
- COSM $1.65
- Technical
- Relative Strength Index (RSI)
- DMN N/A
- COSM 34.83
- Support Level
- DMN N/A
- COSM $0.69
- Resistance Level
- DMN N/A
- COSM $0.73
- Average True Range (ATR)
- DMN 0.00
- COSM 0.05
- MACD
- DMN 0.00
- COSM -0.01
- Stochastic Oscillator
- DMN 0.00
- COSM 0.00
About DMN DAMON INC
Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.